Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where J. Le Bidois is active.

Publication


Featured researches published by J. Le Bidois.


Prenatal Diagnosis | 1999

Prenatal detection of a tetralogy of Fallot with origin of the left pulmonary artery from the ascending aorta in a familial 22q11 microdeletion

Zakhia Saliba; J. Le Bidois; Daniel Sidi; J. Kachaner; Damien Bonnet

Here, we report a case of prenatal diagnosis of anomalous origin of the left pulmonary artery from the ascending aorta associated with a tetralogy of Fallot in a familial form of 22q11 deletion. The mother, who had a normal heart and a velo‐cardio‐facial syndrome, had a first child with a pulmonary atresia plus ventricular septal defect associated with a 22q11 deletion. Prenatal diagnosis during the second pregnancy identified the above‐described cono‐truncal anomaly and FISH study showed a recurrent 22q11 deletion. This case illustrates the intrafamilial variability of cardiac involvement in 22q11 deletion as well as the possibility of diagnosing complex cono‐truncal malformations during fetal life. Copyright


Ultrasound in Obstetrics & Gynecology | 2009

Prenatal diagnosis of cardiac rhabdomyomas: incidence of associated cerebral lesions of tuberous sclerosis complex.

J. Saada; S. Hadj Rabia; Laurent Fermont; J. Le Bidois; L. Bernades-Stein; Jelena Martinovic; P. Sonigo; Yves Dumez; Damien Bonnet; Alexandra Benachi

To determine the prevalence of specific cerebral lesions of tuberous sclerosis complex (TSC) and neurological outcome in cases diagnosed prenatally with cardiac rhabdomyomas.


European Journal of Pediatrics | 1992

Heart transplantation in children: Mid-term results and quality of life

J. Le Bidois; J. Kachaner; Pascal Vouhé; Daniel Sidi; Daniel Tamisier

From 1987 to 1991, heart transplantation was undertaken in 49 infants and children with either end-stage cardiomyopathies (28 patients) or severe congenital heart disease (21 patients including 16 having already been surgically but unsuccessfully treated). Their age ranged from 13 days to 15 years (mean=4.5±4.2 years; median=2.5 years). There were 12 early and 7 late deaths (overall mortality=38%), mainly due to graft dysfunction, acute or chronic rejection, and infectious complications, mostly viral. Optimal criteria in selecting both donors and recipients are crucial to reduce early mortality and should never be transgressed despite the critical shortage of organs. The actuarial probability of survival was 64% at 1 year and 57% at 5 years. Our 30 mid-term survivors (62%) were submitted to a close follow up programme which includes endomyocardial biopsies, even in the very young, since non invasive criteria failed to mark every rejection episode. Maintenance therapy was always steroid-free to start with (cyclosporin + azathioprine) but in almost one half of our oldest survivors, it failed to avoid rejection and we had to add lowdose oral steroids for at least several months. Epstein-Barr virus related lymphoproliferations occurred in four patients, two of whom died and two recovered with specific therapy. Renal function was closely monitored: tubular and interstitial lesions were found on renal biopsies and were associated with moderate functional changes. The quality of life of the children who survived heart transplantation was considered as near normal in a little more than one half of the cases but many issues (late coronary disease, drug toxicity, long-term compliance to follow up and therapy) remain significant concerns for the future.


Fetal Diagnosis and Therapy | 2002

Prenatal Ultrasound May Predict Fetal Response to Therapy in Non-Hydropic Fetuses with Supraventricular Tachycardia

J.-M. Jouannic; J. Le Bidois; Laurent Fermont; Villain E; Dominique Mahieu-Caputo; Yves Dumez; M. Dommergues

Objective: To study the fetal response to prenatal therapy in non-hydropic fetuses with supraventricular tachycardia (SVT) as a function of fetal haemodynamic status at presentation. Study Design: Retrospective study. Material and Methods: Between 1990 and 2000, 40 non-hydropic fetuses presented with SVT. Twenty-eight had reciprocating SVT and 12 had atrial flutter. Ten fetuses had significant tricuspid valve regurgitation. All fetuses were treated prenatally. The main outcome measurement was fetal response to therapy as assessed by the rate of prenatal SVT reduction and by the mean time interval to sinus rhythm restoration. Results: The mean gestational age at presentation was 29 ± 4.9 weeks. Overall, there were 39 liveborns and 1 intrauterine death. Reduction of SVT was achieved prenatally in 32 cases (80%). Among the 30 cases without tricuspid regurgitation, prenatal conversion to sinus rhythm was achieved in 27 cases (90%) with a mean time interval of 7 days. Among the 10 fetuses presenting with tricuspid regurgitation, the rate of prenatal conversion was significantly lower (5/10) and the mean time interval to conversion was significantly longer (24 days; p = 0.04, Mann-Whitney test). In the subgroup treated by digoxin as first-line therapy (n = 32), the interval to sinus rhythm restoration was also significantly higher in the presence of tricuspid regurgitation, with a slightly but not significantly lower reduction rate. Conclusion: The response to prenatal therapy may be poorer in cases presenting with tricuspid regurgitation.


Prenatal Diagnosis | 2015

Pulmonary stenosis in complicated monochorionic twin pregnancies: prevalence, management and outcome

V. Stagnati; G. E. Chalouhi; M. Essaoui; A. Giuseppi; J. Stirnemann; J. Le Bidois; Yves Ville

To review prevalence, management and prognostic factors of pulmonary stenosis (PS) in monochorionic diamniotic (MCDA) pregnancies complicated by twin‐to‐twin transfusion syndrome (TTTS).


Prenatal Diagnosis | 2015

Clinical course and outcome of antenatally detected atrioventricular block: experience of a single tertiary centre and review of the literature

M. Kuleva; J. Le Bidois; A. Decaudin; Villain E; Nathalie Costedoat-Chalumeau; D. Lemercier; Yves Dumez; Yves Ville; Damien Bonnet; L. J. Salomon

The objective is to study the course and outcome of fetuses with congenital atrioventricular block (AVB) in a single centre.


Prenatal Diagnosis | 2003

Fetal hypertension: an insight into the pathogenesis of the twin–twin transfusion syndrome

Dominique Mahieu-Caputo; L. J. Salomon; J. Le Bidois; Laurent Fermont; A. Brunhes; P. Jouvet; Yves Dumez; M. Dommergues


Ultrasound in Obstetrics & Gynecology | 2002

Middle cerebral artery Doppler in fetuses with transposition of the great arteries

J.-M. Jouannic; Alexandra Benachi; Damien Bonnet; Laurent Fermont; J. Le Bidois; Yves Dumez; M. Dommergues


Archives De Pediatrie | 2004

L'information de l'enfant et de sa famille: aspects juridiques

F Chabas; J. Le Bidois


Investigative Ophthalmology & Visual Science | 2008

Micro-Anophthalmos Is Associated With C.H.A.R.G.E.Syndrome

P. Bitoun; E. Pipiras; V. Abadie; J. Le Bidois; B. Benzacken

Collaboration


Dive into the J. Le Bidois's collaboration.

Top Co-Authors

Avatar

Damien Bonnet

Paris Descartes University

View shared research outputs
Top Co-Authors

Avatar

Daniel Sidi

Necker-Enfants Malades Hospital

View shared research outputs
Top Co-Authors

Avatar

Laurent Fermont

Necker-Enfants Malades Hospital

View shared research outputs
Top Co-Authors

Avatar

Yves Dumez

Necker-Enfants Malades Hospital

View shared research outputs
Top Co-Authors

Avatar

J. Kachaner

Necker-Enfants Malades Hospital

View shared research outputs
Top Co-Authors

Avatar

M. Dommergues

Necker-Enfants Malades Hospital

View shared research outputs
Top Co-Authors

Avatar

Villain E

Necker-Enfants Malades Hospital

View shared research outputs
Top Co-Authors

Avatar

Alexandra Benachi

Necker-Enfants Malades Hospital

View shared research outputs
Top Co-Authors

Avatar

Daniel Tamisier

Necker-Enfants Malades Hospital

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge